Most infants with the rare liver disease biliary atresia (BA) show signs of a previous rotavirus infection, suggesting the…
Marisa Horak, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Horak, MS
Mirum Pharmaceuticals is making progress with a quartet of late-stage clinical trials designed to test brelovitug, the company’s experimental…
CHOLANGITIS
NewsStudy indicates which PBC patients may see liver function recovery
Primary biliary cholangitis (PBC) patients who have irreversible liver scarring that affects the organ’s function are more likely to…
FATTY LIVER DISEASE
NewsHK2 protein identified as potential treatment target for MASH: Study
Two proteins called S100A11 and HK2 contribute to the abnormal buildup of fat in the liver that characterizes steatotic…
Backed by millions in U.S. funding, scientists from Johns Hopkins Medicine in Baltimore will be leading a new international consortium…
A global clinical trial testing Mirum Pharmaceuticals’ oral therapy maralixibat in people with itching, or pruritus, due to rare…
Long-term exposure to particles produced from cooking grilled meat can trigger liver damage and cholestasis — slowing or stalling…
Use of the experimental immune-modulating therapy CNP-104 in adults with primary biliary cholangitis (PBC) participating in a U.S. clinical trial led…
FATTY LIVER DISEASE
NewsParental obesity triples risk of early liver disease in children, new study finds
People whose biological parents were overweight or obese at the time of their conception face a greater risk of early…
One-time treatment with VRON-0200 reduced hepatitis B virus (HBV) levels in the blood of most people with chronic hepatitis…